Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits

Sponsor
Tufts University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04961112
Collaborator
(none)
150
1
4
12.8
11.7

Study Details

Study Description

Brief Summary

This study investigates the potential of cranial electrotherapy stimulation to mitigate anxiety induced cognitive deficits

Condition or Disease Intervention/Treatment Phase
  • Device: Cranial Electrotherapy Stimulation
  • Device: Sham Cranial Electrotherapy Stimulation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
All study staff are blinded to active and sham brain stimulation devices until the completion of data collection.
Primary Purpose:
Basic Science
Official Title:
Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits
Actual Study Start Date :
Sep 6, 2021
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental - Induced Anxiety

Participants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. Participants will be told they may receive additional shocks for poor performance during cognitive assessments. Participants will be administered cranial electrotherapy stimulation with a frequency of .5 Hz and a current of 100 microamps during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).

Device: Cranial Electrotherapy Stimulation
Participants will receive cranial electrotherapy stimulation stimulation on one of two separate visits (within-subjects).
Other Names:
  • Transcranial Pulsed Current Stimulation
  • Cranial Electrical Stimulation
  • Experimental: Experimental - No Induced Anxiety

    Participants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. After this procedure, the shock belt will be turned off. Participants will be told they will not receive additional shocks during cognitive assessments. Participants will be administered cranial electrotherapy stimulation with a frequency of .5 Hz and a current of 100 microamps during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).

    Device: Cranial Electrotherapy Stimulation
    Participants will receive cranial electrotherapy stimulation stimulation on one of two separate visits (within-subjects).
    Other Names:
  • Transcranial Pulsed Current Stimulation
  • Cranial Electrical Stimulation
  • Sham Comparator: Sham - Induced Anxiety

    Participants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. Participants will be told they may receive additional shocks for poor performance during cognitive assessments. Participants will be administered sham cranial electrotherapy stimulation with no current during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).

    Device: Sham Cranial Electrotherapy Stimulation
    Participants will receive sham stimulation on one of two separate visits (within-subjects).

    Sham Comparator: Sham - No Induced Anxiety

    Participants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. After this procedure, the shock belt will be turned off. Participants will be told they will not receive additional shocks during cognitive assessments. Participants will be administered sham cranial electrotherapy stimulation with no current during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).

    Device: Sham Cranial Electrotherapy Stimulation
    Participants will receive sham stimulation on one of two separate visits (within-subjects).

    Outcome Measures

    Primary Outcome Measures

    1. Task switching [68 weeks]

      Switch cost (mean switch reaction time- mean stay reaction time)

    2. Working memory (N-back) [68 weeks]

      2-back condition mean accuracy

    3. Inhibition (Stroop) [68 weeks]

      Stroop interference cost (mean incongruent reaction time- mean congruent reaction time)

    4. Processing speed (Simple reaction time task) [68 weeks]

      Mean reaction time

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 28 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Between 18-28 years old
    Exclusion Criteria:
    • History of diagnosis with a neurological or psychiatric disorder.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Tufts University Medford Massachusetts United States 02155

    Sponsors and Collaborators

    • Tufts University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Nathan Ward, Assistant Professor, Tufts University
    ClinicalTrials.gov Identifier:
    NCT04961112
    Other Study ID Numbers:
    • 1908026
    First Posted:
    Jul 14, 2021
    Last Update Posted:
    Jan 19, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Nathan Ward, Assistant Professor, Tufts University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 19, 2022